Product Details

CAT No.# CS-AV-00092
Category Inhibitors
Molecular Weight 588.7
Molecular Formula C30H33FN8O2S
Purity: >98
Synonyms: 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile
Application Notes: NA
References: Desroy N, Housseman C, Bock X, Joncour A, Bienvenu N, Cherel L, Labeguere V, Rondet E, Peixoto C, Grassot JM, Picolet O, Annoot D, Triballeau N, Monjardet A, Wakselman E, Roncoroni V, Le Tallec S, Blanque R, Cottereaux C, Vandervoort N, Christophe T, Mollat P, Lamers M, Auberval M, Hrvacic B, Ralic J, Oste L, van der Aar E, Brys R, Heckmann B. Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methyli midazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis. J Med Chem. 2017 May 1. doi: 10.1021/acs.jmedchem
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
GLPG-1690 Worldwide Suppliers of GLPG-1690 Inhibitors Clearsynth CS-AV-00092

Product rating: 9 GLPG-1690 based on 20 ratings

  1. Inhibitors
  2. GLPG-1690

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B


This page contains information about GLPG-1690 Cas NA and its Inhibitors.

GLPG-1690 GLPG-1690 Worldwide Suppliers of GLPG-1690 Inhibitors Clearsynth NA

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."